Shaikh Nissar, Nawaz Shoaib, Ummunisa Firdous, Shahzad Aamir, Hussain Jazib, Ahmad Kiran, Almohannadi Haleema S, Sharara Hussein Attia
Department of Anesthesia, SICU, Hamad Medical Corporation, Doha, Qatar.
Department of Anesthesia and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar E-mail:
Qatar Med J. 2021 Feb 16;2021(1):4. doi: 10.5339/qmj.2021.4. eCollection 2021.
Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity initially described in 1996. PRES frequently develops in patients with preeclampsia and eclampsia. There is not much literature on risk factors causing PRES in pregnant patients with eclampsia. This study aimed to determine the incidence of PRES in eclampsia, its association with pregnancy, risk factors, and maternal and perinatal outcomes.
All patients who were admitted with eclampsia and developed PRES in an intensive care unit of a tertiary medical facility between 1997 and 2017 were included in the study. Patients' demographics, pregnancy and gestational data, treatment mode, and outcomes were retrospectively obtained from their medical charts/files. Data were entered using SPSS program version 23. Chi-square test was used to compare the variables, and a value of < 0.05 was considered statistically significant.
A total of 151 patients were admitted during the study period, and 25 developed PRES. The diagnosis was common in patients older than 25 years. Eclampsia patients who developed PRES were without any pregnancy-associated comorbidities ( < 0.08). At the time of diagnosis, their gestational age was more than 36 weeks, which was significant ( < 0.04). Incidence was significantly higher in patients presenting with eclampsia and had recurrent seizures ( < 0.01 and 0.002, respectively). Its incidence was significantly higher in postpartum eclampsia patients ( < 0.01). It was also significantly higher in patients who had cesarean section and hypertension treated with labetalol ( < 0.001 and 0.02, respectively). Overall, the maternal mortality rate of eclampsia patients complicated with PRES was 4% in our population.
Of eclampsia patients, 16% developed PRES, which is on the lower side than the reviewed literature (10%-90%). Eclampsia on presentation, recurrent seizures, postpartum eclampsia, cesarean delivery, and labetalol use were associated with increased risk of PRES development.
后部可逆性脑病综合征(PRES)是一种临床和影像学实体,于1996年首次被描述。PRES常发生于子痫前期和子痫患者。关于子痫孕妇发生PRES的危险因素的文献不多。本研究旨在确定子痫患者中PRES的发生率、其与妊娠的关联、危险因素以及孕产妇和围产儿结局。
纳入1997年至2017年间在一家三级医疗机构重症监护病房收治的所有子痫患者且发生PRES的患者。从其病历/档案中回顾性获取患者的人口统计学资料、妊娠和孕周数据、治疗方式及结局。使用SPSS 23版程序录入数据。采用卡方检验比较变量,P值<0.05被认为具有统计学意义。
研究期间共收治151例患者,25例发生PRES。该诊断在25岁以上患者中常见。发生PRES的子痫患者无任何妊娠相关合并症(P<0.08)。诊断时,其孕周超过36周,差异有统计学意义(P<0.04)。子痫伴反复惊厥的患者发生率显著更高(分别为P<0.01和0.002)。产后子痫患者的发生率显著更高(P<0.01)。剖宫产且用拉贝洛尔治疗高血压的患者发生率也显著更高(分别为P<0.001和0.02)。总体而言,我们研究人群中合并PRES的子痫患者孕产妇死亡率为4%。
子痫患者中,16%发生PRES,这低于综述文献中的比例(10% - 90%)。子痫初发、反复惊厥、产后子痫、剖宫产及使用拉贝洛尔与发生PRES的风险增加相关。